Dementia Today.net

Site updated at Wednesday, 22 June 2016

Living with Dementia

Memory Disorders Program

Georgetown physician leads national resveratrol study for Alzheimer’s disease

A national, phase II clinical trial examining the effects of resveratrol on individuals with mild to moderate dementia due to Alzheimer’s disease has begun as more than two dozen academic institutions recruit volunteers in the coming months. R. Scott Turner, M.D., Ph.D., director of Georgetown University Medical Center’s Memory Disorders Program, is the lead… Georgetown physician leads national resveratrol study for Alzheimer’s disease   



Alzheimer’s Disease

sleepiness1 - autosomal dominant gene mutation1 - medicare1 - amyloid β1 - delta-9-tetrahydrocannabinol1 - phosphorylated tau1 - social withdrawal1 - korsakoff amnesic syndrome1 - difficulties with swallowing1 - neurotrophic factor1 - diabetes mellitus1 - ad diagnosing1 - gene therapy1 - amyvid2 - quality sleep1 - igf-11 - amyloid-beta plaque1 - executive function1 - signs of alzheimer's1 - neocortex1 - sleep apnea1 - moderate intensity aerobic exercise1 - mirna1 - vessel disease1 - management of dementia1 - hypertension and dementia1 - eeg1 - huntington gene1 - resveratrol1 - major depression1 -